J&J Sues Boehringer Ingelheim Over Arbitration Dispute

(Corrects spelling of Ingelheim in first paragraph.)

Johnson & Johnson (JNJ) sued a unit of rival drugmaker Boehringer Ingelheim Gmbh over whether a dispute about an agreement must be heard by an arbitrator.

To contact the reporter on this story: Jef Feeley in Wilmington, Delaware at jfeeley@bloomberg.net

To contact the editor responsible for this story: Fred Strasser at fstrasser@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.